Executive Assistant

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

ESSENTIAL JOB FUNCTIONS:

Kura Oncology is looking for a dynamic individual, who will have the ability to exercise good judgment in a variety of situations, with strong written and verbal communication, administrative, and organizational skills. The Executive Assistant should have the ability to maintain a realistic balance among multiple priorities and will have the ability to work independently on projects, from conception to completion. The Executive Assistant will provide specialized and advanced administrative support to the Chief Scientific Officer and SVP Manufacturing and Supply Chain and other leaders as needed. We are looking for a motivated self-starter and strong communicator with an elevated level of commitment, ownership, and sense of urgency.

• Responsible for creating and coordinating all travel, including complex travel with expected changes, and creating expense reports
• Provide calendar and meeting support
• Serve as the head of the San Deigo Events Committee to include planning, scheduling and executing corporate events and meetings
• Manage events budget annually
• Assist with basic presentation support, including creating and editing slide decks
• Coordinate internal team meetings (regional and national) to ensure smooth logistics and execution
• Coordinate all contracts with contracting department and process POs to completion

JOB SPECIFICATIONS:

• Bachelor’s degree preferred or a combination of experience and training
• Minimally 5 years of experience supporting Senior level management
• This person is required to be in person in the San Diego office typically Tuesday, Wednesday and Thursday and more when needed
• Ideally this person would have experience within the biotech/pharmaceutical industry
• Proficient with basic computer skills, including typing, and proficiency in Microsoft Office Suite (Word, Excel,
• PowerPoint, Outlook), Concur, WebEx/MS Teams, SharePoint, and Office 365
• Experience with event management is highly desired
• Project management experience is strongly preferred
• Ability to exercise discretion and independent judgment regarding highly sensitive and external communications
• Excellent verbal and written communication skills, with a strong command of English grammar
• Ability to work well with diverse personalities and maintain a collaborative approach to team efforts
• Excellent professionalism and strong interpersonal skills are essential for success in this role
• Must have a positive “can-do” attitude, demonstrate excellent judgment, and be capable of working independently
• Flexibility to accommodate rapidly changing priorities and deadlines is a mut

The base range for this role is $102,000 - $120,000. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

#LI-RM1

Kura’s Values that are used for candidate selection and performance assessments:

• We work as one for patients
• We are goal-focused and deliver with excellence
• We are science-driven courageous innovators
• We strive to bring out the best in each other and ourselves

The Kura Package

• Career advancement/ development opportunities
• Competitive comp package
• Bonus
• 401K + Employer contributions
• Generous stock options
• ESPP Plan
• 20 days of PTO to start
• 18 Holidays  (Including Summer & Winter Break)
• Generous Benefits Package with a variety of plans available with a substantial employer match
• Paid Paternity/Maternity Leave
• In-Office Catered lunches
• Home Office Setup
• Lifestyle Spending Stipend
• Commuter Stipend (Boston Office)
• Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline consists of small molecule drug candidates designed to target cancer signaling pathways. Ziftomenib, a once-daily, oral menin inhibitor, is the first and only investigational therapy to receive Breakthrough Therapy Designation from the U.S. Food and Drug Administration (“FDA”) for the treatment of relapsed/refractory (“R/R”) NPM1-mutant acute myeloid leukemia (“AML”). In November 2024, Kura Oncology entered into a global strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize ziftomenib for AML and other hematologic malignancies. Enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML has been completed, and in the second quarter of 2025, the companies announced the FDA’s acceptance of a New Drug Application for ziftomenib for the treatment of adult patients with R/R NPM1-mutant AML and assignment of a Prescription Drug User Fee Act target action date of November 30, 2025. Kura Oncology and Kyowa Kirin are also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. KO-2806, a next-generation farnesyl transferase inhibitor, is being evaluated in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies for patients with various solid tumors. Tipifarnib, a potent and selective farnesyl transferase inhibitor, is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status. 

If you are a California resident, please see the attached Privacy Notice CA Privacy Notice